Xsome Biotech
PrivateCompany Overview
Xsome Biotech is a biotechnology company that develops exosome therapeutics and novel drug delivery carriers for a variety of diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
exosome therapeuticsdrug delivery platformidiopathic pulmonary fibrosisIPFinhalable drug deliveryAcute Respiratory Distress SyndromeARDScell-free therapyregenerative medicinerespiratory therapeuticsinhaled biologicsclinical-stage biotechsecretome therapeuticstissue regenerationLSC-Exo
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xsome Biotech Comparables
Compare Xsome Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nano24 | 85% | |
| OmniSpirant Therapeutics | 80% | |
| Direct Biologics | 77% | |
Xsome Biotech Funding Rounds
Historical fundraising activity
Xsome Biotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Xsome Biotech's valuation, stock price, and market status.
See something wrong or outdated?